XML 20 R8.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Cash flows from operating activities:    
Net income $ 20,710 $ 1,127
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 1,950 1,973
Net amortization of premiums on securities 1,206 562
Provision (benefit) for credit losses (1,981) 13,915
Share-based compensation 216 332
Deferred income tax expense (benefit) 1,658 (276)
Proceeds from sale of loans held for sale 21,314 9,934
Originations of loans held for sale (21,616) (9,280)
Income on company owned life insurance (657) (465)
Net gain on sale of loans held for sale (1,078) (252)
Net gain on investment securities (74) (221)
Net loss (gain) on other assets 5 (64)
Noncash restructuring charges against assets 6  
Decrease (increase) in other assets 12,818 (31,708)
(Decrease) increase in other liabilities (14,172) 18,745
Net cash provided by operating activities 20,305 4,322
Cash flows from investing activities:    
Purchases of available for sale securities (204,695) (44,812)
Purchases of held to maturity securities (1,265) (1,364)
Proceeds from principal payments, maturities and calls on available for sale securities 32,416 30,947
Proceeds from principal payments, maturities and calls on held to maturity securities 16,783 13,827
Proceeds from sales of securities available for sale 26,675 3,157
Net loan originations (60,135) (27,029)
Purchases of company owned life insurance, net of proceeds received (12) (7)
Proceeds from sales of other assets   427
Purchases of premises and equipment (290) (1,196)
Cash consideration paid for acquisition, net of cash acquired (713)  
Net cash used in investing activities (191,236) (26,050)
Cash flows from financing activities:    
Net increase in deposits 437,647 231,510
Net decrease in short-term borrowings (5,300) (166,000)
Repurchase of preferred stock (6)  
Purchases of common stock for treasury (5,963) (196)
Cash dividends paid to common and preferred shareholders (4,535) (4,365)
Net cash provided by financing activities 421,843 60,949
Net increase in cash and cash equivalents 250,912 39,221
Cash and cash equivalents, beginning of period 93,878 112,947
Cash and cash equivalents, end of period $ 344,790 $ 152,168